Home Health Care News April 16, 2024
Home-based care dealmaking remains in a lull, one it hasn’t been able to shake since the historical M&A highs of 2020 and 2021.
“We didn’t expect it to be that flat and that consistent for 2023,” Mark Kulik, senior managing director at M&A firm The Braff Group, said during a presentation at Home Health Care News’ Capital + Strategy conference last week. “That was disappointing by any measure. If you speak to anyone, certainly at our firm, it was a disappointing year for ourselves with the lack of transactions and the lack of deal flow.”
Kulik noted that there are a number of forces negatively impacting health care dealmaking, including high interest rates, inflation, U.S. staffing shortages and global unrest.
...